Search

everythinglearnresearchcommunity

for

Search:↓

Weekly azathioprine pulse is a better alternative to corticosteroids for treating alopecia areata due to fewer side effects.

Health warnings and public health actions led to a significant drop in flutamide prescriptions for women, but off-label use still continues.

Treating psoriasis with UVB light three times a week is faster than twice a week, and certain medications and lifestyle factors affect psoriasis treatment outcomes.

Methotrexate effectively treated a 2-year-old's generalized pustular psoriasis without side effects.

SH-MSCs can improve hair growth by balancing gene expressions in fluconazole-related hair loss.

Rituximab effectively managed a difficult case of juvenile lupus with complications, reducing the need for steroids.

Infliximab can cause SAPHO syndrome, which may improve with Spesolimab and methotrexate.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

An arthritis drug helped a person with severe hair loss regrow their hair.

Mesalazine showed limited effectiveness in treating children with severe alopecia areata.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Scalp psoriasis treatments like strong corticosteroids and vitamin D3 analogues are effective, especially when combined.

Ustekinumab treatment didn't prevent frontal fibrosing alopecia.

Topical tacrolimus can effectively treat erosive pustular dermatosis and related hair loss.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

Glucocorticoids for progressive muscular dystrophy in children don't improve muscle strength or function but do increase certain side effects.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Adalimumab can cause hair loss and scalp issues in some psoriasis patients.

Oral cyclosporine is more effective and safer than betamethasone for treating alopecia areata.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

The compound from Rhododendron mucronulatum roots may help treat male pattern hair loss.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Tofacitinib is an effective and safe treatment for alopecia areata.